Low-dose-rate iodine-125 seed air kerma strength measurement intercomparison

被引:0
|
作者
Poder, Joel [1 ,2 ]
Smith, Ryan [3 ]
Haworth, Annette [4 ]
机构
[1] St George Hosp, Canc Care Ctr, Kogarah, NSW 2217, Australia
[2] Univ Wollongong, Ctr Med Radiat Phys, Wollongong, NSW, Australia
[3] Alfred Hosp, Alfred Hlth Radiat Oncol, Melbourne, Vic, Australia
[4] Univ Sydney, Sch Phys, Camperdown, NSW, Australia
关键词
I-125; Brachytherapy; Air kerma strength; Calibration; Intercomparison; EMITTING BRACHYTHERAPY SOURCES; RADIATION-THERAPY; RANDOMIZED-TRIAL; CALIBRATION; RECOMMENDATIONS; CHAMBER;
D O I
10.1016/j.brachy.2019.10.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: The purpose of this study was to investigate the rate of compliance of air kerma strength (AKS) measurements of iodine-125 (1-125) seeds with international recommendations by departments in Australia and determine the potential impact of noncompliance. METHODS AND MATERIALS: To achieve this aim, we present an intercomparison of AKS measurements for a single I-125 seed performed by 11 radiotherapy departments in Australia. Measurements were performed at two sites, with each participating department traveling to one of the two host sites and measuring the AKS using their own equipment and local protocols. Each of the AKS measurements was compared with each other and the manufacturer-certified AKS. RESULTS: Nine of the 11 participating departments measured AKS fell within +/- 3% of the manufacturer's calibration certificate value, whereas all participating departments measured AKS within +/- 5% of the manufacturer's calibration certificate value. The total spread of the measured AKS among the 11 departments was 7.7%. Only two of the 11 participating departments complied with international recommendations and had their well chamber calibrated within the last 2 years. In addition, 2 of the 11 departments used a well chamber calibrated that was calibrated with a different seed model used during the intercomparison, whereas 4 of the 11 departments calibrated their well chamber "in-house" using a factory-calibrated seed provided by the seed manufacturer. CONCLUSIONS: A significant variation in the methods used and frequency of calibration of well chambers were observed among the participating departments. The results of this study support the international recommendations on frequency and methodology of well chamber calibration. Failure to follow these recommendations significantly increases the uncertainty in AKS measurement of I-125 seeds. Crown Copyright (C) 2020 Published by Elsevier Inc. on behalf of American Brachytherapy Society. All rights reserved.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 50 条
  • [41] The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy
    Katsumi Hirose
    Masahiko Aoki
    Mariko Sato
    Hiroyoshi Akimoto
    Yasuhiro Hashimoto
    Atsushi Imai
    Noritaka Kamimura
    Hideo Kawaguchi
    Yoshiomi Hatayama
    Ichitaro Fujioka
    Mitsuki Tanaka
    Chikara Ohyama
    Yoshihiro Takai
    Japanese Journal of Radiology, 2016, 34 : 718 - 723
  • [42] Long-term results of Iodine-125 seed brachytherapy in low and intermediate risk prostate carcinoma
    Guinot, J.
    Gonzalez-Perez, V.
    Casanova, J.
    Santos, M. A.
    De los Dolores, V.
    La Rosa, A.
    Sanchez-Rodriguez, A.
    Laborda, A.
    Canos, S.
    Cotanda, V.
    Guardino, C.
    Tortajada, M. I.
    Arribas, L.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S497 - S498
  • [43] Determinants of disease control following iodine-125 permanent seed brachytherapy in low risk prostate cancer
    Morton, G
    Loblaw, DA
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S38 - S39
  • [44] The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy
    Hirose, Katsumi
    Aoki, Masahiko
    Sato, Mariko
    Akimoto, Hiroyoshi
    Hashimoto, Yasuhiro
    Imai, Atsushi
    Kamimura, Noritaka
    Kawaguchi, Hideo
    Hatayama, Yoshiomi
    Fujioka, Ichitaro
    Tanaka, Mitsuki
    Ohyama, Chikara
    Takai, Yoshihiro
    JAPANESE JOURNAL OF RADIOLOGY, 2016, 34 (11) : 718 - 723
  • [45] Ocular malignancies treated with iodine-125 low dose rate (LDR) brachytherapy at a single high-volume institution: A retrospective review
    Richards, Zachary
    Nguyen, My-Lien
    Kutteh, Michael
    Ahmad, Salahuddin
    Henson, Christina
    Firestone, Brian
    Herman, Terence S.
    Herman, Tania De La Fuente
    MEDICAL DOSIMETRY, 2022, 47 (03) : 273 - 279
  • [46] Development of an Australian secondary standard for the reference air kerma rate measurement of 125I seeds
    Davies J.B.
    Mo L.
    Alexiev D.
    Australasian Physics & Engineering Sciences in Medicine, 2005, 28 (3): : 196 - 199
  • [47] LOW-DOSE-RATE BRACHYTHERAPY FOR LOW- AND INTERMEDIATE-RISK PROSTATE CANCER: A DOSE-RESPONSE ANALYSIS FOR 3392 CONSECUTIVE 125-IODINE MONOTHERAPY PATIENTS
    Morris, W. James
    Spadinger, Ingrid
    Halperin, Ross
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S28 - S28
  • [48] Comparison of cellular damage response to low-dose-rate 125I seed irradiation and high-dose-rate gamma irradiation in human lung cancer cells
    Chen, Honghong
    Bao, Yizhong
    Yu, Lei
    Jia, Rongfei
    Cheng, Wenying
    Shao, Chunlin
    BRACHYTHERAPY, 2012, 11 (02) : 149 - 156
  • [49] RESULTS OF COMPARISON FOR TWO DIFFERENT MODEL 125I SEED SOURCE AND TWO DIFFERENT AIR KERMA STRENGTH (AKS) SEEDS MEASUREMENT.
    Zuchora, A.
    Langan, B.
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 : S45 - S45
  • [50] Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy
    Fekete, Charles-Antoine Collins
    Plamondon, Mathieu
    Martin, Andre-Guy
    Vigneault, Eric
    Verhaegen, Frank
    Beaulieu, Luc
    MEDICAL PHYSICS, 2014, 41 (10)